EE+ POEM Archive
Omalizumab is better than placebo in alleviating symptoms in kids with severe atopic dermatitis (ADAPT)
Omalizumab is better than placebo in alleviating symptoms in kids with severe atopic dermatitis (ADAPT) is a topic covered in the EE+ POEM Archive.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Omalizumab Is Better Than Placebo in Alleviating Symptoms in Kids With Severe Atopic Dermatitis (ADAPT)." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314965/all/Omalizumab_is_better_than_placebo_in_alleviating_symptoms_in_kids_with_severe_atopic_dermatitis__ADAPT_.
Omalizumab is better than placebo in alleviating symptoms in kids with severe atopic dermatitis (ADAPT). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314965/all/Omalizumab_is_better_than_placebo_in_alleviating_symptoms_in_kids_with_severe_atopic_dermatitis__ADAPT_. Accessed March 22, 2023.
Omalizumab is better than placebo in alleviating symptoms in kids with severe atopic dermatitis (ADAPT). (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314965/all/Omalizumab_is_better_than_placebo_in_alleviating_symptoms_in_kids_with_severe_atopic_dermatitis__ADAPT_
Omalizumab Is Better Than Placebo in Alleviating Symptoms in Kids With Severe Atopic Dermatitis (ADAPT) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2023 March 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314965/all/Omalizumab_is_better_than_placebo_in_alleviating_symptoms_in_kids_with_severe_atopic_dermatitis__ADAPT_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Omalizumab is better than placebo in alleviating symptoms in kids with severe atopic dermatitis (ADAPT)
ID - 1314965
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314965/all/Omalizumab_is_better_than_placebo_in_alleviating_symptoms_in_kids_with_severe_atopic_dermatitis__ADAPT_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
